Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, U7 small nuclear 47 pseudogene** (RNU7-47P) is classified as a pseudogene that is related by sequence similarity to functional U7 small nuclear RNA genes but does not code for a functional product[1][6][7]. U7 small nuclear RNA (snRNA) itself is an essential component of the U7 small nuclear ribonucleoprotein (snRNP), required for 3' end processing of replication-dependent histone pre-mRNA[4][5]. However, pseudogenes like RNU7-47P are non-functional genomic sequences that arise from gene duplication or retrotransposition; they do not produce active RNA or protein and lack biological activity or therapeutic relevance[1][6][7]. There is no known direct implication of this pseudogene in disease, no drugs known to target it, and it is not considered a therapeutic drug target[1][6][7]. **Key rationale and clarifications**: - This target is a *pseudogene*, not a functional RNA, receptor, enzyme, or other protein; therefore, it is not considered a therapeutic target[1][6][7]. - There is no evidence in available resources describing any biological function, disease association, or pharmacological relevance for RNU7-47P specifically[1][6][7]. - Pseudogenes like this may share sequence similarity with functional genes (such as RNU7-1 for U7 snRNA) but are generally transcriptionally inactive and biologically inert[1][6][7]. - "U7 small nuclear RNA" (also known as RNU7-1) is functionally important and involved in histone pre-mRNA processing, but RNU7-47P is not; it is a non-coding, non-functional genomic element[2][3][4][5]. If you are seeking information on the *functional* U7 snRNA or its gene (RNU7-1), that is a distinct and biologically relevant target involved in mRNA processing[2][3][4][5]. The entry above applies strictly to the RNU7-47P pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 47 pseudogene (RNU7-47P).